108 related articles for article (PubMed ID: 22813547)
1. Autoimmune disease.
Itani MH; Uthman I
Lupus; 2012 Oct; 21(12):1370-1. PubMed ID: 22813547
[No Abstract] [Full Text] [Related]
2. Systemic lupus erythematosus following HPV immunization or infection?
Soldevilla HF; Briones SF; Navarra SV
Lupus; 2012 Feb; 21(2):158-61. PubMed ID: 22235047
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune/auto-inflammatory syndrome induced by adjuvants (ASIA) after quadrivalent human papillomavirus vaccination in Colombians: a call for personalised medicine.
Anaya JM; Reyes B; Perdomo-Arciniegas AM; Camacho-Rodríguez B; Rojas-Villarraga A
Clin Exp Rheumatol; 2015; 33(4):545-8. PubMed ID: 25962455
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus vaccine and systemic lupus erythematosus.
Gatto M; Agmon-Levin N; Soriano A; Manna R; Maoz-Segal R; Kivity S; Doria A; Shoenfeld Y
Clin Rheumatol; 2013 Sep; 32(9):1301-7. PubMed ID: 23624585
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study.
Mok CC; Ho LY; Fong LS; To CH
Ann Rheum Dis; 2013 May; 72(5):659-64. PubMed ID: 22589375
[TBL] [Abstract][Full Text] [Related]
6. Vaccination in autoimmune animal models.
Tomijenovic L; Arango MT; Agmon-Levin N
Isr Med Assoc J; 2014 Oct; 16(10):657-8. PubMed ID: 25438463
[No Abstract] [Full Text] [Related]
7. Autoimmune hepatitis type 2 following anti-papillomavirus vaccination in a 11-year-old girl.
Della Corte C; Carlucci A; Francalanci P; Alisi A; Nobili V
Vaccine; 2011 Jun; 29(29-30):4654-6. PubMed ID: 21596082
[TBL] [Abstract][Full Text] [Related]
8. No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines.
Mitchell TC; Casella CR
Curr Opin Immunol; 2017 Aug; 47():17-25. PubMed ID: 28728074
[TBL] [Abstract][Full Text] [Related]
9. Recommendations and barriers to vaccination in systemic lupus erythematosus.
Garg M; Mufti N; Palmore TN; Hasni SA
Autoimmun Rev; 2018 Oct; 17(10):990-1001. PubMed ID: 30103044
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus.
Urowitz MB; Anton A; Ibanez D; Gladman DD
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1517-20. PubMed ID: 22034113
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study.
Denny L; Hendricks B; Gordon C; Thomas F; Hezareh M; Dobbelaere K; Durand C; Hervé C; Descamps D
Vaccine; 2013 Nov; 31(48):5745-53. PubMed ID: 24091311
[TBL] [Abstract][Full Text] [Related]
12. Involvement of chronic epipharyngitis in autoimmune (auto-inflammatory) syndrome induced by adjuvants (ASIA).
Hotta O; Tanaka A; Torigoe A; Imai K; Ieiri N;
Immunol Res; 2017 Feb; 65(1):66-71. PubMed ID: 27592233
[TBL] [Abstract][Full Text] [Related]
13. The impact of human papillomavirus and human papillomavirus vaccination among rheumatology patients.
O'Connor MB; Bond U; Phelan MJ
J Clin Rheumatol; 2010 Oct; 16(7):355. PubMed ID: 20921856
[No Abstract] [Full Text] [Related]
14. Immunogenicity of the bivalent human papillomavirus vaccine in adolescents with juvenile systemic lupus erythematosus or juvenile dermatomyositis.
Heijstek MW; Scherpenisse M; Groot N; Wulffraat NM; Van Der Klis FR
J Rheumatol; 2013 Sep; 40(9):1626-7. PubMed ID: 23997002
[No Abstract] [Full Text] [Related]
15. Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.
Grimaldi-Bensouda L; Guillemot D; Godeau B; Bénichou J; Lebrun-Frenay C; Papeix C; Labauge P; Berquin P; Penfornis A; Benhamou PY; Nicolino M; Simon A; Viallard JF; Costedoat-Chalumeau N; Courcoux MF; Pondarré C; Hilliquin P; Chatelus E; Foltz V; Guillaume S; Rossignol M; Abenhaim L;
J Intern Med; 2014 Apr; 275(4):398-408. PubMed ID: 24206418
[TBL] [Abstract][Full Text] [Related]
16. The human papillomavirus vaccination is not associated with risk of multiple sclerosis or other demyelinating diseases.
Perkins RB; Christiansen CL
Evid Based Med; 2015 Jun; 20(3):116. PubMed ID: 25841246
[No Abstract] [Full Text] [Related]
17. Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine.
Kuroda Y; Nacionales DC; Akaogi J; Reeves WH; Satoh M
Biomed Pharmacother; 2004 Jun; 58(5):325-37. PubMed ID: 15194169
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus vaccine in patients with systemic lupus erythematosus.
Pellegrino P; Carnovale C; Perrone V; Salvati D; Gentili M; Antoniazzi S; Clementi E; Radice S
Epidemiology; 2014 Jan; 25(1):155-6. PubMed ID: 24296931
[No Abstract] [Full Text] [Related]
19. [A case of systemic lupus erythematosus (SLE) following Human papillomavirus (HPV) vaccination].
Ito H; Noda K; Hirai K; Ukichi T; Furuya K; Kurosaka D
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(2):145-9. PubMed ID: 27212601
[TBL] [Abstract][Full Text] [Related]
20. Systemic lupus erythematosus induced by interferon β1 therapy in a patient with multiple sclerosis.
Bahri DM; Khiari H; Essouri A; Laadhar L; Zaraa I; Mrabet A; Meddeb N; Sellami S
Fundam Clin Pharmacol; 2012 Apr; 26(2):210-1. PubMed ID: 21323997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]